Question 1

What is Novo Nordisk A/S's P/E Ratio?

Accepted Answer

Novo Nordisk A/S (NVO) P/E Ratio is 10.13x based on the latest available daily valuation data on Chartloom.

Question 2

How is P/E Ratio calculated?

Accepted Answer

P/E Ratio = Current Stock Price ÷ Trailing 12-Month (TTM) Diluted EPS (or Market Cap ÷ TTM Net Income). Chartloom divides stock price by trailing twelve-month EPS, calculated by dividing TTM net income by the weighted-average share count from filings. Note: Variations in share-count conventions across data providers may cause slight differences in reported P/E multiples.

Question 3

How to interpret P/E Ratio for Novo Nordisk A/S?

Accepted Answer

Interpreting P/E Ratio for Novo Nordisk A/S depends on industry, growth expectations, profitability, and peer multiples.

Question 4

How do you interpret Price-to-Earnings Ratio (P/E)?

Accepted Answer

Higher P/E often reflects stronger growth expectations; lower P/E may indicate value or higher risk.

Question 5

What should investors consider when analyzing Price-to-Earnings Ratio (P/E)?

Accepted Answer

One-time items can distort trailing P/E—always check the underlying earnings quality.

Question 6

How is Price-to-Earnings Ratio (P/E) used in stock analysis?

Accepted Answer

Trailing P/E is based on reported GAAP results and is one of the most widely used valuation metrics.

Novo Nordisk A/S

Novo Nordisk A/S

Novo Nordisk A/S (NVO) P/E Ratio: 10.13x

Explore Novo Nordisk A/S's full valuation history

Novo Nordisk A/S (NVO) P/E Ratio: 10.13x

Explore Novo Nordisk A/S's full valuation history